skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Medtech analysis on tap

Meddevicetracker | Pharma intelligence

Meddevicetracker offers both a bottom-up and top-down look at the world of medical devices, diagnostics, and advanced drug delivery systems. Anticipate upcoming filings, research clinical trial dates and data, and access market size information and expert forecasts, all in one place.

How it works

Our flexible interface lets you access real-time analysis of device markets, companies and products. Meddevicetracker coverage includes:

  • Cardiovascular
  • Oncology
  • Neuromodulation
  • Autoimmune disorders
  • Wound care
  • Drug delivery Technology
  • Diabetes
  • Orthopedics
  • Women's health

 

How it helps

Use Meddevicetracker to understand market trends, find partnership opportunities and stay on top of key milestones.

  • Identify upcoming device regulatory events/filings
  • Search for medtech clinical trial starts and data
  • Find historical and forecasted procedure volumes data
  • Monitor medication delivery technologies and identify partnership opportunities
  • Quantify market size for medical devices or diseases
  • Discover forecasted market share of medical devices by type

What's included

real time medtech market intelligence pharma intelligence

Real-time medtech market intelligence

Stay current and never miss a large impact event in the device market

unparalleled medtech market coverage case studies achievement pharma intelligence

Unparalleled medtech market coverage

With hundreds of event and catalyst types and thousands of clinical trials, companies and products covered, you can quickly find the intelligence you need to make strategic business decisions

company analysis pharma intelligence

Device and disease market forecast

Quantify the market size for devices or diseases

discover market opportunities indepth analysis pharma intelligence

Discover market opportunities

Understand the device competitive landscape and identify unmet clinical needs

identify partnership opportunities dedicated account manager pharma intelligence

Identify partnership opportunities

Monitor drug delivery technologies by device type and locate major players and technologies

keep up with medical trial milestones treatment trends analysis pharma intelligence

Keep up with medtech clinical trial milestones

Easily locate device trial information and search for clinical trial starts and data

device regulation market intelligence treatment trends analysis pharma intelligence

Device regulation market intelligence

Identify upcoming device regulatory events/filings

Market forecasts for your chosen device or disease

Market forecasts for your chosen device or disease

Market forecasts for your chosen device or disease

Meddevicetracker

;

Meet the team

Management

Richard Faint

Management, Head of Medtech

UK

Richard Faint

Richard specializes in

  • Cardiovascular
  • CNS
  • Immunology & Inflammation
  • Infectious Diseases
  • Oncology

+25 year(s) experience

Management

Gail Parziale

Management, ​Head of Intelligence Editorial Operations
Gail Parziale

Gail specializes in

  • Commercial Strategy
  • Clinical Trials

+20 year(s) experience

Management

Stacey Fong

Management, Content Manager

USA

Stacey Fong

Stacey specializes in

  • Commercial Strategy

+9 year(s) experience

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907

Or email us your inquiry, so we can provide you the best possible customer service:
Pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: